On April 28, 2021, the federal Department of Health and Human Services (HHS) released new practice guidelines for prescribing buprenorphine to treat opioid use disorder (OUD). The new guidelines are effective immediately. Under these guidelines, prescribers seeking to prescribe buprenorphine for no more than 30 consumers at a time will no longer be required to complete training hours or certify that they can provide counseling and psychosocial services. Currently to qualify for a Drug Enforcement Administration (DEA) waiver to treat 30 consumers at a time, prescribers must complete training hours and certify that they can provide psychosocial services. The current . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.